Prediction of extracapsular extension in prostate cancer using the Likert scale combined with clinical and pathological parameters

Prediction of extracapsular extension in prostate cancer using the Likert scale combined with clinical and pathological parameters

AbstractThis study aimed to investigate the independent clinical, pathological, and radiological factors associated with extracapsular extension in radical prostatectomy specimens and to improve the accuracy of predicting extracapsular extension of prostate cancer before surgery.MethodsFrom August 2...

Full description

Bibliographic Details
Main Authors:	Jun-guang Wang, Bin-tian Huang, Li Huang, Xia Zhang, Pei-pei He, Jun-bo Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-08-01
Series:	Frontiers in Oncology
Subjects:	prostate cancer prostate-specific antigen biopsy grade group extracapsular extension magnetic resonance imaging
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1229552/full

Similar Items

Imaging classification of prostate cancer with extracapsular extension and its impact on positive surgical margins after laparoscopic radical prostatectomy
by: Jun-Guang Wang, et al.
Published: (2024-03-01)

Radiologic-pathologic correlation of prostatic cancer extracapsular extension (ECE)
by: Adalgisa Guerra, et al.
Published: (2023-05-01)

The feasibility of distance to the tumor of biopsy cores to estimate the extracapsular extension
by: Chang Lim Hyun, et al.
Published: (2023-12-01)

Extracapsular extension risk assessment using an artificial intelligence prostate cancer mapping algorithm
by: Alan Priester, et al.
Published: (2024-10-01)

Validation of user-friendly models predicting extracapsular extension in prostate cancer patients
by: Leandro Blas, et al.
Published: (2023-01-01)

Side-specific, Microultrasound-based Nomogram for the Prediction of Extracapsular Extension in Prostate Cancer
by: Adriana M. Pedraza, et al.
Published: (2023-02-01)

Multi-parametric MRI of the prostate: Factors predicting extracapsular extension at the time of radical prostatectomy
by: Geoffrey S. Gaunay, et al.
Published: (2017-01-01)

Prediction of extracapsular extension of prostate cancer by MRI radiomic signature: a systematic review
by: Adalgisa Guerra, et al.
Published: (2024-08-01)

Early biomarkers of extracapsular extension of prostate cancer using MRI-derived semantic features
by: Adalgisa Guerra, et al.
Published: (2022-12-01)

Factors associated with biochemical recurrence of prostate cancer post radical prostatectomy
by: Ezekiel E. Radebe, et al.
Published: (2024-05-01)

Added value of shear-wave elastography in the prediction of extracapsular extension and seminal vesicle invasion before radical prostatectomy
by: Yi-Kang Sun, et al.
Published: (2023-01-01)

Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy
by: Kwang Suk Lee, et al.
Published: (2017-03-01)

Evaluation of concordance between histopathological prognostic findings from prostate needle biopsy samples and serum prostate-specific antigen levels
by: Cengiz Kocak
Published: (2019-03-01)

Evaluation of the pathologic results of prostate biopsies in terms of age, Gleason score and PSA level: Our experience and review of the literature
by: Selcuk Sarıkaya, et al.
Published: (2014-12-01)

Percentage of free prostate-specific antigen (PSA) is a useful method in deciding to perform prostate biopsy with higher core numbers in patients with low PSA cut-off values
by: Hasan Yilmaz, et al.
Published: (2015-06-01)

What Should Be the Prostate Specific Antigen Threshold for Prostate Biopsy?
by: Hasan Deliktaş, et al.
Published: (2017-06-01)

Prostatic specific antigen for prostate cancer detection
by: Lucas Nogueira, et al.
Published: (2009-10-01)

Implications of the European Association of Urology Recommended Risk Assessment Algorithm for Early Prostate Cancer Detection
by: Bas Israël, et al.
Published: (2022-09-01)

Prostate cancer detection rate in patients with fluctuating prostate-specific antigen levels on the repeat prostate biopsy
by: Yong Hyun Park, et al.
Published: (2014-03-01)

Pathological characteristics and predictive factors of prostate biopsy in patients with serum PSA levels between 0 and 4.0 ng/ml
by: Rui Su, et al.
Published: (2022-07-01)

Extended use of Prostate Health Index and percentage of [-2]pro-prostate-specific antigen in Chinese men with prostate specific antigen 10–20 ng/mL and normal digital rectal examination
by: Peter Ka-Fung Chiu, et al.
Published: (2016-09-01)

Incidence of histological prostatitis and its correlation with PSA density
by: Affonso Celso Piovesan, et al.
Published: (2009-11-01)

Prostate Specific Antigen Level and Gleason Score in Indonesian Prostate Cancer Patients
by: Muhammad Imam Al Kautsar Herawan, et al.
Published: (2024-09-01)

Clinical application of machine learning models in patients with prostate cancer before prostatectomy
by: Adalgisa Guerra, et al.
Published: (2024-02-01)

Chronic inflammation of the prostate type IV with respect to risk of prostate cancer
by: Antonio B. Porcaro, et al.
Published: (2014-09-01)

Validity of Prostate Health Index and Percentage of [-2] Pro-Prostate-Specific Antigen as Novel Biomarkers in the Diagnosis of Prostate Cancer: Omani Tertiary Hospitals Experience
by: Safana S. Al Saidi, et al.
Published: (2017-07-01)

Research of the best screen interval for middle aged and elderly Chinese males with baseline prostate specific antigen levels <2.0 ng/mL in prostate cancer screening
by: Yu Chen, et al.
Published: (2024-09-01)

Transrectal Ultrasound Guided Prostatic Biopsy and its Complications: A Descriptive Cross-sectional Study
by: Robin Joshi
Published: (2020-01-01)

How to avoid prostate biopsy in men with Prostate Image-Reporting and Data System 3 lesion? Development and external validation of new biopsy indication using prostate health index density
by: Jae Yeon Kim, et al.
Published: (2023-09-01)

Effect on prostatic specific antigen by a short time treatment with a Curcuma extract: A real life experience and implications for prostate biopsy
by: Andrea Fabiani, et al.
Published: (2018-06-01)

A Study on TRUS-Guided Prostatic Biopsy and its Correlation with Serum PSA, Gleason Score and Grade-Grouping in a Tertiary Care Centre of Eastern India
by: GOPINATH BARUI, et al.
Published: (2019-03-01)

Effect of Finasteride on PSA and Histopathological Results in Patients Undergoing Prostate Biopsy
by: Saman Farshid, et al.
Published: (2022-12-01)

A positive magnetic resonance spectroscopic imaging with negative initial biopsy may predict future detection of prostate cancer
by: Durgesh Kumar Dwivedi, et al.
Published: (2012-01-01)

Utility of transperineal template-guided mapping prostate biopsy in biopsy-naïve men with PI-RADS 1-2 on multiparametric magnetic resonance imaging
by: Jong Hoon Lee, et al.
Published: (2024-09-01)

BIOMARKERS FOR DIAGNOSING OF PROSTATE CANCER: THE PRESENT AND THE FUTURE
by: L. M. Rapoport, et al.
Published: (2018-05-01)

Multiparametric Magnetic Resonance Imaging of the Prostate and Prostate-specific Membrane Positron Emission Tomography Prior to Prostate Biopsy (MP4 Study)
by: Henry H. Woo, et al.
Published: (2023-01-01)

Survival of patients with prostate cancer and normal PSA levels treated by radical prostatectomy
by: Marcos F. Dall'oglio, et al.
Published: (2005-06-01)

Outcomes and complications after transrectal ultrasound-guided prostate biopsy: A single-center study involving 425 consecutive patients
by: Jhen-Hao Jhan, et al.
Published: (2018-01-01)

Combination of PI-RADS score and PSAD can improve the diagnostic accuracy of prostate cancer and reduce unnecessary prostate biopsies
by: Changming Wang, et al.
Published: (2022-11-01)

Repeat Prostate-specific Antigen Testing Improves Risk-based Selection of Men for Prostate Biopsy After Magnetic Resonance Imaging
by: Petter Davik, et al.
Published: (2024-07-01)